SR
Sakshi Ravindra Lalvani
About Sakshi Ravindra Lalvani
Data last updated:
Sakshi Ravindra Lalvani is a Director at Salutecare Innovations Private Limited (since 2025) and Director at Sarone Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Salutecare Innovations Private Limited U46596GJ2025PTC165905 | Director | 05 Aug 2025 | 2025 | Active | |
| Sarone Pharmaceuticals Private Limited U46497GJ2023PTC146504 | Director | 28 Nov 2023 | 2023 | Active |
Board colleagues of Sakshi Ravindra Lalvani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravindra Laxmandas Lalvani | 10191088 | Salutecare Innovations Private Limited , Sarone Pharmaceuticals Private Limited | Director |
| Ashish Kantilal Shah | 06511633 | Sarone Pharmaceuticals Private Limited | Director |
| Dhruti Rahul Zaveri | 10546873 | Sarone Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sakshi Ravindra Lalvani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sakshi Ravindra Lalvani
Sakshi Ravindra Lalvani currently holds 2 directorships: Salutecare Innovations Private Limited (Director, since 05 Aug 2025); Sarone Pharmaceuticals Private Limited (Director, since 28 Nov 2023).
Sakshi Ravindra Lalvani was first appointed on 28 Nov 2023 as Director at Sarone Pharmaceuticals Private Limited. The most recent appointment on record is 05 Aug 2025 at Salutecare Innovations Private Limited.
The current boards of Sakshi Ravindra Lalvani's companies include Ravindra Laxmandas Lalvani (Salutecare Innovations Private Limited), Ashish Kantilal Shah (Sarone Pharmaceuticals Private Limited), Dhruti Rahul Zaveri (Sarone Pharmaceuticals Private Limited).